BioCentury on BioBusiness,
EPA to press ahead with long-awaited regulations
Monday, December 20, 1993
WASHINGTON - During the first half of 1994, the Environmental Protection Agency
hopes to publish long-awaited regulations covering genetically engineered microorganisms,
including experimental use of microbial pesticides and transgenic plants that
produce pesticidal substances.
The government has been developing the regulations since the mid-1980s, but
disputes within the executive branch about the degree of regulation that should
be imposed on biotechnology have caused repeated delays in publishing the proposals.
EPA's failure to provide a clear regulatory framework has "eroded the confidence
of the investment community of the various industries we regulate," said
Lynn Goldman, assistant administrator at the agency. "We can't afford to
do that anymore."
The White House Office
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2016 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]